Salarius Pharmaceuticals Statistics
Total Valuation
SLRX has a market cap or net worth of $2.21 million. The enterprise value is -$3.40 million.
Market Cap | 2.21M |
Enterprise Value | -3.40M |
Important Dates
The next estimated earnings date is Thursday, May 9, 2024, before market open.
Earnings Date | May 9, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
SLRX has 4.31 million shares outstanding. The number of shares has increased by 53.66% in one year.
Shares Outstanding | 4.31M |
Shares Change (YoY) | +53.66% |
Shares Change (QoQ) | -13.04% |
Owned by Insiders (%) | 6.73% |
Owned by Institutions (%) | 6.09% |
Float | 3.59M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 0.42 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.02, with a Debt / Equity ratio of 0.05.
Current Ratio | 5.02 |
Quick Ratio | n/a |
Debt / Equity | 0.05 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -198.00% and return on invested capital (ROIC) is -231.22%.
Return on Equity (ROE) | -198.00% |
Return on Assets (ROA) | -135.20% |
Return on Capital (ROIC) | -231.22% |
Revenue Per Employee | n/a |
Profits Per Employee | -$6.27M |
Employee Count | 2 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -71.16% in the last 52 weeks. The beta is 1.00, so SLRX's price volatility has been similar to the market average.
Beta (1Y) | 1.00 |
52-Week Price Change | -71.16% |
50-Day Moving Average | 0.57 |
200-Day Moving Average | 0.71 |
Relative Strength Index (RSI) | 47.86 |
Average Volume (30 Days) | 110,312 |
Short Selling Information
The latest short interest is 268,900, so 6.23% of the outstanding shares have been sold short.
Short Interest | 268,900 |
Short Previous Month | 14,387 |
Short % of Shares Out | 6.23% |
Short % of Float | 7.49% |
Short Ratio (days to cover) | 1.00 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -12.89M |
Pretax Income | -12.54M |
Net Income | -12.54M |
EBITDA | -12.53M |
EBIT | -12.54M |
Earnings Per Share (EPS) | -$3.84 |
Balance Sheet
The company has $5.90 million in cash and $289,643 in debt, giving a net cash position of $5.61 million or $1.30 per share.
Cash & Cash Equivalents | 5.90M |
Total Debt | 289,643 |
Net Cash | 5.61M |
Net Cash Per Share | $1.30 |
Equity / Book Value | 5.29M |
Book Value Per Share | 1.23 |
Working Capital | 5.22M |
Cash Flow
Operating Cash Flow | -12.85M |
Capital Expenditures | n/a |
Free Cash Flow | -12.85M |
FCF Per Share | -$3.94 |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
SLRX does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -53.66% |
Shareholder Yield | -53.66% |
Earnings Yield | -568.25% |
FCF Yield | -581.99% |
Analyst Forecast
Price Target | n/a |
Price Target Difference | n/a |
Analyst Consensus | n/a |
Analyst Count | n/a |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on October 17, 2022. It was a reverse split with a ratio of 1:25.
Last Split Date | Oct 17, 2022 |
Split Type | Reverse |
Split Ratio | 1:25 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 1 |